Biomarker Services

Firalis provides a comprehensive range of biomarker services from research to clinical trials in key therapeutic areas. Flexible stratification at scientific and technical levels supports biomarker discovery, validation, evaluation and qualification activities. Using our strong expertise and a cutting-edge laboratory equipment, we develop and deliver solutions for biomarker assays customized to your projects.

Proteomics

Proteomics

Genomics / Transcriptomics

Genomics \ Transcriptomics
Flow Cytometry

Flow Cytometry
Assay Development

Assay Development
Monoclonal Antibodies

Monoclonal Antibodies
Biobanking

Biobanking

Biomarker Data Analysis

Biomarker Data Analysis
Firalis icon

Biomarker Regulatory Consultancy

 

Our partnerships with the pharma industry have resulted in a high sense of quality and reliability in the data we deliver. Clients are invited to choose from our assay menu and use validation data available ad hoc or from a customized procedure.

Image1

 

 

Firalis is certified ISO 13485 (GMP compliant) and ISO 9001 for the development and production of CE-marked assays, certified NF S 96-900 for its biobank and accredited1 ISO 17025 (GCLP compliant) for testing laboratory.

Please do not hesitate to contact us at sales@firalis.com to get additional information on our technical platforms and expertise.

1Accreditation N┬║ 8-3139 on the following methods, Scope available on www.cofrac.fr

Please find here our General Terms and Conditions of Sales for Services (Conditions Generales de Vente et de Prestations de Services)